Midland FL Infectious Diseases is categorized under Doctors in Orange City, FL and active since 2008.
Midland FL Infectious Diseases was established in 2008, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Amber Hatch, Office Manager at the company’s single location by writing to 955 Town Center Drive # 100, Orange City, Florida FL 32763 or by phoning (386) 228-0661. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Midland FL Infectious Diseases |
| Contact Person: | Amber Hatch, Office Manager |
| Address: | 955 Town Center Drive # 100, Orange City, Florida 32763 |
| Phone Number: | (386) 228-0661 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Midland FL Infectious Diseases was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Amber Hatch, Office Manager for inquiries that concern Midland FL Infectious Diseases by calling the company number (386) 228-0661, as your correspondence is most welcome. Additionally, the physical location of the single location of Midland FL Infectious Diseases can be found at the coordinates 28.90782,-81.28822 as well as the street address 955 Town Center Drive # 100 in Orange City, Florida 32763.
For its online presence, you may visit Midland FL Infectious Diseases’s website at and engage with its social media outlets through on Twitter and on Facebook.